Olanzapine vs placebo for nausea from first chemo
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are starting a new chemotherapy with oxaliplatin, irinotecan, or carboplatin for the first time.
- You are 18 years or older.
- You are not pregnant or breastfeeding.
- You have not vomited in the last 24 hours.
- You do not have a bowel blockage, uncontrolled brain tumors, or severe liver/kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
This trial tests whether the drug olanzapine can reduce breakthrough vomiting in children who still vomit despite standard preventive medicines. It aims to improve comfort during cancer treatment.
This trial tests whether the drug olanzapine can help reduce side effects of chemotherapy when given before surgery for stomach cancer, potentially helping patients feel better and complete their treatment.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.
Hear when a new Chemotherapy-induced Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.